Marzano S.; Miglietta G.; Morigi R.; Marinello J.; Arleo A.; Procacci M.; Locatelli A.; Leoni A.; Pagano B.; Randazzo A.; Amato J.; Capranico G., Balancing Affinity, Selectivity, and Cytotoxicity of Hydrazone-Based G-Quadruplex Ligands for Activation of Interferon β Genes in Cancer Cells, «JOURNAL OF MEDICINAL CHEMISTRY», 2022, 65, pp. 12055 - 12067 [articolo]Open Access
Jessica Marinello, Andrea Arleo, Marco Russo, Maria Delcuratolo, Francesca Ciccarelli, Yves Pommier, Giovanni Capranico., Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway, «BRITISH JOURNAL OF CANCER», 2022, 127, pp. 1214 - 1225 [articolo]Open Access
Visioli A.; Giani F.; Trivieri N.; Pracella R.; Miccinilli E.; Cariglia M.G.; Palumbo O.; Arleo A.; Dezi F.; Copetti M.; Cajola L.; Restelli S.; Papa V.; Sciuto A.; Latiano T.P.; Carella M.; Amadori D.; Gallerani G.; Ricci R.; Alfieri S.; Pesole G.; Vescovi A.L.; Binda E., Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies, «EBIOMEDICINE», 2019, 44, pp. 346 - 360 [articolo]Open Access
Mangia, Alessandra; Susser, Simone; Piazzolla, Valeria; Agostinacchio, Ernesto; De Stefano, Giulio; Palmieri, Vincenzo; Spinzi, Giancarlo; Carraturo, Immacolata; Potenza, Domenico; Losappio, Ruggero; Arleo, Andrea; Miscio, Maria; Santoro, Rosanna; Sarrazin, Christoph; Copetti, Massimiliano, Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience, «JOURNAL OF HEPATOLOGY», 2017, 66, pp. 711 - 717 [articolo]
Mangia, A.; Arleo, A.; Piazzolla, V.; Santoro, R.; Petruzzellis, D.; Miscio, M.; Squillante, M.M., Sustained Virological Responses (SVR) of 97% in Genotype 2 (GT-2) Patients with F3/4 Stage of Fibrosis Treated with Sofosbuvir (SOF) and Weight-Based Ribavirin (RBV): A Real Life, Single Centre Experience, «JOURNAL OF HEPATOLOGY», 2016, 64, pp. S246 - S247 [abstract]
Mangia, A.; Arleo, A.; Copetti, M.; Miscio, M.; Piazzolla, V.; Santoro, R.; Squillante, M.M., The Combination of Daclatasvir and Sofosbuvir for Curing Genotype 2 Patients who cannot Tolerate Ribavirin, «JOURNAL OF HEPATOLOGY», 2016, 64, pp. S742 - S742 [abstract]
Mangia A.; Arleo A.; Copetti M.; Miscio M.; Piazzolla V.; Santoro R.; Squillante M.M., The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin, «LIVER INTERNATIONAL», 2016, 36, pp. 971 - 976 [articolo]
Arleo A.; Mangia A., The current treatment of hepatitis C, «MINERVA GASTROENTEROLOGICA E DIETOLOGICA», 2016, 62, pp. 167 - 182 [articolo]
